Showing 1–50 of 267 results

+
 Quick View

anti-mouse

Anti-Mouse PD-1 In Vivo Antibody – Low Endotoxin (RMP1-14) [ICH1132]

$320.00 – $6,000.00
2020 FDA Approvals Ado-trastuzumab-emtansine
+
 Quick View

anti-human

Ado-trastuzumab emtansine Biosimilar – Research Grade [ICH4014]

$1,144.00 – $2,601.00
+
 Quick View

anti-mouse

Anti-Mouse PD-L1 In Vivo Antibody – Low Endotoxin (10F.9G2) [ICH1086]

$320.00 – $2,378.00
2020 FDA Approvals Aflibercept
+
 Quick View

anti-human

Aflibercept Biosimilar – Research Grade [ICH4015]

$600.00 – $2,601.00
Western Blot of Atezolizumab Biosimilar ICH4018
+
 Quick View

anti-human

Atezolizumab Biosimilar – Research Grade [ICH4018]

$718.00 – $4,161.00
Western Blot of Adalimumab Biosimilar ICH40012020 FDA Approvals Adalimumab
+
 Quick View

anti-human

Adalimumab Biosimilar – Research Grade [ICH4001]

$718.00 – $4,161.00
+
 Quick View

anti-mouse

Anti-Mouse PD-1 In Vivo Antibody – Low Endotoxin (29F.1A12) [ICH1091]

$320.00 – $2,378.00
+
 Quick View

anti-mouse

Anti-Mouse Ly-6G In Vivo Antibody – Low Endotoxin (1A8) [ICH1089]

$326.00 – $2,425.00
Western Blot of Pembrolizumab Biosimilar ICH40292020 FDA Approvals for Pembrolizumab
+
 Quick View

anti-human

Pembrolizumab Biosimilar – Research Grade [ICH4029]

$718.00 – $7,700.00
2020 FDA Approvals Ipilimumab
+
 Quick View

anti-human

Ipilimumab Biosimilar – Research Grade [ICH4025]

$718.00 – $4,161.00
+
 Quick View

anti-mouse

Anti-CD3e In Vivo Antibody – Low Endotoxin (145-2C11) [ICH1041]

$326.00 – $2,425.00
+
 Quick View

Antibodies

Rat IgG2a In Vivo Isotype Control – Low Endotoxin (1-1) [ICH2244]

$326.00 – $2,425.00
+
 Quick View

anti-human

Theralizumab Biosimilar – Research Grade [ICH5023]

$300.00 – $4,161.00
+
 Quick View

anti-human

Natalizumab Biosimilar – Research Grade [ICH4037]

$704.00 – $7,700.00
+
 Quick View

Flow Cytometry

Bulk Human IgG4 Isotype Control (IB4) [ICH2257]

$388.00 – $2,425.00
+
 Quick View

Isotype Controls

Syrian Hamster IgG Isotype Control for In Vivo – Low Endotoxin [ICH2253]

$326.00 – $2,182.00
2020 FDA Approvals for Pertuzumab
+
 Quick View

anti-human

Pertuzumab Biosimilar – Research Grade [ICH4030]

$718.00 – $4,161.00
2020 FDA Approvals for Alemtuzumab
+
 Quick View

anti-human

Alemtuzumab Biosimilar – Research Grade [ICH4002]

$718.00 – $4,161.00
+
 Quick View

anti-mouse

Anti-Mouse CD32/CD16 In Vivo Antibody – Low Endotoxin (2.4G2) [ICH1056]

$326.00 – $2,425.00
+
 Quick View

anti-human

Blinatumomab Biosimilar – Research Grade [ICH5025]

$718.00 – $4,161.00
+
 Quick View

Flow Cytometry

Bulk Human IgG1 Isotype Control (IB1) [ICH2254]

$388.00 – $2,425.00
+
 Quick View

anti-mouse

Anti-Mouse H-2b In Vivo Antibody – Low Endotoxin (B8-24-3) [ICH1154]

$326.00 – $2,425.00
2020 FDA Approvals for Ranibizumab
+
 Quick View

anti-human

Ranibizumab Biosimilar – Research Grade [ICH4031]

$300.00 – $4,161.00
2020 FDA Approvals for Panitumumab
+
 Quick View

anti-human

Panitumumab Biosimilar – Research Grade [ICH4028]

$718.00 – $4,161.00
Western Blot of Avelumab Biosimilar ICH40172020 FDA Approvals Avelumab
+
 Quick View

anti-human

Avelumab Biosimilar – Research Grade [ICH4017]

$718.00 – $4,161.00
+
 Quick View

anti-human

Bulk anti-Human CD14 antibody (UCHM-1) [ICH1009]

$326.00 – $2,182.00
+
 Quick View

anti-human

Bulk anti-Human CD19 antibody (SJ25-C1) [ICH1011]

$326.00 – $2,182.00
+
 Quick View

Isotype Controls

Mouse IgG1 Isotype Control for In Vivo – Low Endotoxin (HKSP) [ICH2247]

$326.00 – $2,425.00
+
 Quick View

anti-human

Varlilumab Biosimilar – Research Grade [ICH5022]

$718.00 – $7,500.00
+
 Quick View

anti-human

Urelumab Biosimilar – Research Grade [ICH5015]

$718.00 – $4,161.00
+
 Quick View

anti-human

Etanercept Biosimilar – Research Grade [ICH4022]

$718.00 – $4,161.00
2020 FDA Approvals for Ustekinumab
+
 Quick View

anti-human

Ustekinumab Biosimilar – Research Grade [ICH4034]

$718.00 – $4,161.00
2020 FDA Approvals for Trastuzumab
+
 Quick View

anti-human

Trastuzumab Biosimilar – Research Grade [ICH4013]

$718.00 – $4,161.00
2020 FDA Approvals for Ofatumumab
+
 Quick View

anti-human

Ofatumumab Biosimilar – Research Grade [ICH4027]

$718.00 – $4,161.00
2020 FDA Approvals Eculizumab
+
 Quick View

anti-human

Eculizumab Biosimilar – Research Grade [ICH4005]

$300.00 – $4,161.00
2020 FDA Approvals Denosumab
+
 Quick View

anti-human

Denosumab Biosimilar – Research Grade [ICH4019]

$718.00 – $4,161.00
2020 FDA Approvals Bevacizumab
+
 Quick View

anti-human

Bevacizumab Biosimilar – Research Grade [ICH4003]

$718.00 – $4,161.00
2020 FDA Approvals Alirocumab
+
 Quick View

anti-human

Alirocumab Biosimilar – Research Grade [ICH4016]

$718.00 – $15,000.00
+
 Quick View

anti-bovine

Bulk anti-human TGF-B1,2,3 antibody (1D11.1) [ICH1090]

$326.00 – $2,182.00
+
 Quick View

anti-mouse

Anti-Mouse NK1.1 In Vivo Antibody – Low Endotoxin (PK136) [ICH1128]

$326.00 – $2,425.00
+
 Quick View

anti-mouse

Anti-Mouse LPAM1 In Vivo Antibody – Low Endotoxin (DATK32) [ICH1105]

$326.00 – $2,182.00
+
 Quick View

anti-mouse

Anti-Mouse IL-1R In Vivo Antibody – Low Endotoxin (JAMA-147) [ICH1117]

$326.00 – $2,182.00
+
 Quick View

anti-human

Bulk anti-Human MHC Class I antibody (W6/32) [ICH1023]

$326.00 – $2,182.00
+
 Quick View

anti-human

Bulk anti-Human CD56 antibody (ERIC-1) [ICH1015]

$326.00 – $2,182.00
+
 Quick View

anti-human

Bulk anti-Human CD71 antibody (T56/14) [ICH1018]

$326.00 – $2,182.00
+
 Quick View

anti-human

Bulk anti-Human CD11b antibody (ICRF44) [ICH1007]

$326.00 – $2,182.00
+
 Quick View

anti-human

Bulk anti-Human CD8 antibody (UCHT-4) [ICH1005]

$326.00 – $2,182.00
+
 Quick View

anti-human

Bulk anti-Human CD3 antibody (UCHT-1) [ICH1002]

$326.00 – $2,182.00
+
 Quick View

anti-human

Bulk anti-Human CD16 antibody (3G8) [ICH1010]

$326.00 – $2,182.00
+
 Quick View

anti-mouse

Anti-Mouse CD8 beta In Vivo Antibody – Low Endotoxin (53-5.8) [ICH1046]

$326.00 – $2,425.00